Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer
Clinical trial NCT06134765 · UNKNOWN
Trial details
- NCT number
- NCT06134765
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2024-10-30
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.